AU5429896A - Rage tumor rejection antigens - Google Patents
Rage tumor rejection antigensInfo
- Publication number
- AU5429896A AU5429896A AU54298/96A AU5429896A AU5429896A AU 5429896 A AU5429896 A AU 5429896A AU 54298/96 A AU54298/96 A AU 54298/96A AU 5429896 A AU5429896 A AU 5429896A AU 5429896 A AU5429896 A AU 5429896A
- Authority
- AU
- Australia
- Prior art keywords
- tumor rejection
- rejection antigens
- rage tumor
- rage
- antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40801595A | 1995-03-21 | 1995-03-21 | |
US08/408015 | 1995-03-21 | ||
US08/530569 | 1995-09-20 | ||
US08/530,569 US5939526A (en) | 1995-03-21 | 1995-09-20 | Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof |
PCT/US1996/004037 WO1996029409A2 (en) | 1995-03-21 | 1996-03-21 | Rage tumor rejection antigens |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5429896A true AU5429896A (en) | 1996-10-08 |
AU705768B2 AU705768B2 (en) | 1999-06-03 |
Family
ID=27020105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54298/96A Ceased AU705768B2 (en) | 1995-03-21 | 1996-03-21 | Rage tumor rejection antigens |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0815229A2 (en) |
JP (1) | JPH11506904A (en) |
AU (1) | AU705768B2 (en) |
CA (1) | CA2211448A1 (en) |
NZ (1) | NZ306122A (en) |
WO (1) | WO1996029409A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7284598A (en) * | 1997-05-05 | 1998-11-27 | Incyte Pharmaceuticals, Inc. | Rage1-like protein |
WO1999004265A2 (en) * | 1997-07-17 | 1999-01-28 | Ludwig Institute For Cancer Research | Cancer associated nucleic acids and polypeptides |
JP2002514400A (en) * | 1998-05-13 | 2002-05-21 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | Tumor-associated antigens encoded by the reverse strand of a novel ubiquitously expressed gene |
US6686147B1 (en) * | 1998-07-15 | 2004-02-03 | Ludwig Institute For Cancer Research | Cancer associated antigens and uses therefor |
WO2000020587A2 (en) * | 1998-10-05 | 2000-04-13 | Ludwig Institute For Cancer Research | Cancer associated antigens and uses therefor |
WO2000020586A2 (en) * | 1998-10-05 | 2000-04-13 | Ludwig Institute For Cancer Research | Renal cancer associated antigens and uses therefor |
US7338670B2 (en) | 2005-04-14 | 2008-03-04 | Duke University | Use of an agent that restores tissue perfusion and oxygenation |
US20110311448A1 (en) * | 2007-11-02 | 2011-12-22 | Ann Marie Schmidt | Antibody to rage and uses for in vivo imaging or for targeting therapy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE280180T1 (en) * | 1992-08-31 | 2004-11-15 | Ludwig Inst Cancer Res | ISOLATED NONAPEPTIDE DERIVED FROM MAGE-3 GENE AND PRESENTED BY HLA-A1 AND APPLICATIONS THEREOF |
-
1996
- 1996-03-21 EP EP96911399A patent/EP0815229A2/en not_active Withdrawn
- 1996-03-21 AU AU54298/96A patent/AU705768B2/en not_active Ceased
- 1996-03-21 CA CA002211448A patent/CA2211448A1/en not_active Abandoned
- 1996-03-21 WO PCT/US1996/004037 patent/WO1996029409A2/en not_active Application Discontinuation
- 1996-03-21 NZ NZ306122A patent/NZ306122A/en unknown
- 1996-03-21 JP JP8528658A patent/JPH11506904A/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU705768B2 (en) | 1999-06-03 |
JPH11506904A (en) | 1999-06-22 |
NZ306122A (en) | 1999-06-29 |
EP0815229A2 (en) | 1998-01-07 |
WO1996029409A3 (en) | 1996-11-07 |
WO1996029409A2 (en) | 1996-09-26 |
CA2211448A1 (en) | 1996-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3811495A (en) | Antibodies | |
AU4042195A (en) | Anti-alphaV-integrin monoclonal antibody | |
EP0737501A3 (en) | Strainer | |
AU4877896A (en) | Preparation | |
AU5365296A (en) | Human monoclonal antibody against lung carcinoma | |
ZA962280B (en) | RAGE tumor rejection antigens | |
AUPN178995A0 (en) | Antigen composition | |
AU7166896A (en) | Cancer treatment | |
AU7314896A (en) | Filtering | |
AU5429896A (en) | Rage tumor rejection antigens | |
AU6820796A (en) | Antigenic preparations | |
AU4396396A (en) | Baby-bathing aid | |
AU7520396A (en) | Abl-interactor protein | |
AU5284296A (en) | Immune-evading proteins | |
AU1866597A (en) | Photochrome diaryl-3H-naphthopyrane | |
AU1809695A (en) | Tumor associated monoclonal antibody 123av16 | |
AU7321496A (en) | Deep well filters | |
AU6153396A (en) | E6ap-binding proteins | |
AU7862291A (en) | Modified antibodies | |
AU4502797A (en) | Immunological therapy for cancer | |
AU5132996A (en) | Codominance-mediated toxins | |
AU7623296A (en) | Microcellulose-based preparations | |
AU1844999A (en) | Self-setting-spring-steel wire-fish-hook | |
AU2012697A (en) | Bottle-opener | |
AUPN546895A0 (en) | Pattet slide |